bioSyntagma is a precision medicine company dedicated to transforming how cancer is treated by providing deep data on the uniqueness of each person’s cancer. The company’s Molecular Fingerprint™ (mPrint™) platform creates a comprehensive, multi-omic and spatial profile of tissue to get a complete and informed understanding of the patient’s cancer so they can be matched with relevant therapies and recommended course of actions that prevent acquired drug resistance. bioSyntagma’s mPrint™ platform serves the needs of clinicians, academic researchers, and drug developers to advance the implementation of precision medicine for cancer treatment.
Company Details
- Employees
- 2
- Founded
- 2015
- Address
- 275 N. Gateway Drive,
- in****@****gma.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- biosyntagma.com
- Keywords
- biomarker discovery, expression analysis, data visualization, pharmaceutical research, artificial intelligence, spatial 'omics.
- HQ
- Phoenix, Arizona
Biosyntagma Questions
Biosyntagma's website is biosyntagma.com
Biosyntagma's LinkedIn profile is https://www.linkedin.com/company/biosyntagma
Biosyntagma has
2 employees.
View email and phone details for 2
employees at Biosyntagma.
Biosyntagma's industry is
Biotechnology Research
Biosyntagma's top competitors are
Vanbrunt Group,
Atlas Ai,
Viable Insights,
Advisorclarity,
Gobuyleads.com,
Actual Metrics,
American Technology Cloud, Llc,
All Things Eq,
Adviserly,
Enhanced Info.
Biosyntagma's support email address is info@biosyntagma.com
Biosyntagma's categories are Biotechnology Research
Biosyntagma's founding year is 2015
